California Nanotechnologies Corp. (TSXV:CNO)

TSXV:CNO Income Statement

Financials in millions USD. Fiscal year is March - February.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Revenue	6.22	3.34	1.38	1.08	0.79
Revenue Growth (YoY)	86.51%	141.51%	27.78%	36.11%	-4.39%
Cost of Revenue	1.64	1.01	0.39	0.32	0.34
Gross Profit	4.59	2.33	0.99	0.76	0.46
Selling, General & Admin	2.1	1.18	0.6	0.41	0.44
Research & Development	0	-	-	-	0
Operating Expenses	3.2	1.7	0.8	0.55	0.58
Operating Income	1.38	0.64	0.19	0.21	-0.12
Interest Expense	-0.19	-0.11	-0.11	-0.08	-0.06
Currency Exchange Gain (Loss)	-0	0	-0	0	-0
Other Non Operating Income (Expenses)	-1.19	-0.15	0.01	-0.01	0
EBT Excluding Unusual Items	-0	0.38	0.08	0.12	-0.18
Gain (Loss) on Sale of Assets	0.01	-	-	-	-
Other Unusual Items	-	-	-	0.08	0.06
Pretax Income	0.01	0.38	0.08	0.2	-0.12
Income Tax Expense	0.17	-	0	-	-
Net Income	-0.16	0.38	0.08	0.2	-0.12
Net Income to Common	-0.16	0.38	0.08	0.2	-0.12
Net Income Growth	-	378.51%	-60.24%	-	-
Shares Outstanding (Basic)	45	35	32	32	31
Shares Outstanding (Diluted)	45	39	33	32	31
Shares Change (YoY)	16.63%	17.88%	2.25%	1.99%	-
EPS (Basic)	-0.00	0.01	0.00	0.01	-0.00
EPS (Diluted)	-0.00	0.01	0.00	0.01	-0.00
EPS Growth	-	311.01%	-61.73%	-	-
Free Cash Flow	0.8	0.09	0.54	0.14	0.08
Free Cash Flow Per Share	0.02	0.00	0.02	0.00	0.00
Gross Margin	73.66%	69.88%	71.68%	70.03%	57.83%
Operating Margin	22.20%	19.03%	13.69%	19.42%	-15.33%
Profit Margin	-2.54%	11.44%	5.77%	18.55%	-15.22%
Free Cash Flow Margin	12.80%	2.70%	38.88%	12.58%	10.62%
EBITDA	1.59	0.75	0.3	0.32	0.01
EBITDA Margin	25.61%	22.56%	21.99%	29.84%	1.02%
D&A For EBITDA	0.21	0.12	0.11	0.11	0.13
EBIT	1.38	0.64	0.19	0.21	-0.12
EBIT Margin	22.20%	19.03%	13.69%	19.42%	-15.33%
Effective Tax Rate	1598.94%	-	4.83%	-	-
Advertising Expenses	0.11	0.1	0.04	0.04	0.03

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.